BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
MIRM upcoming catalysts
Mirum Pharmaceuticals, Inc.: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 3 readout(s) and 1 FDA event(s). Subscribe to MIRM (.ics).
Drugs: Volixibat
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No upcoming PDUFA date or AdCom found. | |||||
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2027-01 est. | P2 | Mirum Pharmaceuticals, Inc. MIRM | NCT05050136 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis | Primary Biliary Cholangitis; PBC | active not recruiting | 333 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| 2026-09-25 | FDA approval | approved | MIRUM MIRM | ATEBRIOZ | Approved 2026-09-25: ATEBRIOZ (NDA221198 ORIG1) |
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-08 est. | P3 | Mirum Pharmaceuticals, Inc. MIRM | NCT07298330 A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) | Chronic Hepatitis D Infection | active not recruiting | 80 |
| 2026-07-29 | P3 | Mirum Pharmaceuticals, Inc. MIRM | NCT06553768 Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) | Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) | active not recruiting | 90 |
| 2026-02-20 | P2 | Mirum Pharmaceuticals, Inc. MIRM | NCT04663308 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Primary Sclerosing Cholangitis | active not recruiting | 182 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.